Annexon (NASDAQ:ANNX) highlighted progress across three programs targeting the classical complement pathway during a fireside chat at TD Cowen’s 46th Annual Healthcare Conference, with President and ...

Curling is Danny Casper’s life. But two years ago, he had to give it up after an autoimmune disease diagnosis. Now he's skip ...

C1q is the initiating component of the classical complement pathway and plays a critical role in activating macrophages and microglia through receptor-mediated signaling. Dysregulated C1q activity ...

The Pinch Volunteer Fire Department and community are rallying around one of their first responders as she battles a rare ...

Rare disease day is observed annually on the last day of February to spread awareness on certain conditions that can impact on patients lives.

Lucander, CEO, Hansa Biopharma said: " With the PDUFA date now set, we are one step closer to potentially offering imlifidase as a transformative therapy option for patients who today have very ...

If approved, imlifidase will be the first treatment to address highly sensitized patients awaiting kidney transplantation. LUND, Sweden, March 4, 2026 /PRNewswire/ -- Hansa Biopharma ...

This initial obsession led me to earn a degree in human and sports nutrition. This training, by fueling my curiosity and interest, opened the door for me to become a science journalist specializing in ...

The American College of Physicians (ACP) issued updated vaccine practice points for physicians that advise adults aged 75 or ...

For the purposes of the calculations in this report, the committee estimated that there are approximately 7,000 new infections with streptococcus, group B (GBS) and 430 deaths in infants and 4,000 new ...

Even when they may have had a chance of surviving that asphyxia, the likelihood of catching infections while in the newborn ...